These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9011166)

  • 21. [Comparative study of ketotiphen and oxatomide (repeated skin- and nasal provocation)].
    Bittera I; Kadocsa E; Gyurkovits K
    Orv Hetil; 1990 Feb; 131(7):355-8. PubMed ID: 1970150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Perennial rhinitis: antihistaminic and anti-inflammatory treatment].
    Eseverri JL; Botey J; Marín AM
    Allergol Immunopathol (Madr); 1997; 25(1):1-9. PubMed ID: 9148645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis.
    Yamada K; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Hayashi M; Kishimoto K; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():169-77. PubMed ID: 9879417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis.
    Fokkens WJ; Scadding GK
    Pediatr Allergy Immunol; 2004 Jun; 15(3):261-6. PubMed ID: 15209960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
    Pécoud A; Zuber P; Kolly M
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of levocabastine nasal spray in nasal provocation tests.
    Palma-Carlos AG; Palma-Carlos ML; Rombaut N
    Int J Clin Pharmacol Res; 1988; 8(1):25-30. PubMed ID: 2896636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical efficacy and safety of levocarbastine++ in the therapy in children suffering from seasonal allergic rhinitis and conjunctivitis who are less than 12 year of age].
    Kurzawa R; Kossek M; Doniec Z; Mazurek H; Urbanek E; Sak-Kopytyńska I; Radliński J; Bukowczan Z
    Pol Merkur Lekarski; 1998 May; 4(23):269-72. PubMed ID: 9825660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 30. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
    Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
    Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal allergy.
    Frankland AW
    Aviat Space Environ Med; 1984 May; 55(5):425-8. PubMed ID: 6145407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of ebastine in children.
    Simons FE; Watson WT; Simons KJ
    J Pediatr; 1993 Apr; 122(4):641-6. PubMed ID: 8096545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and therapeutic outcomes of patients with localized mucosal allergy.
    Kim YH; Jang TY
    Am J Rhinol Allergy; 2010; 24(4):e89-92. PubMed ID: 20819459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells.
    Yamauchi Y; Fujikura T; Shimosawa T
    Allergol Int; 2007 Jun; 56(2):171-7. PubMed ID: 17460445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
    Herman D; Garay R; Le Gal M
    Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
    Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
    J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy.
    Lin HC; Lin PW; Su CY; Chang HW
    Laryngoscope; 2003 Apr; 113(4):673-8. PubMed ID: 12671427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.